19764-31-9Relevant articles and documents
Structures and properties of a diastereoisomeric molecular compound of (2S,3S)- and (2R,3S)-N-acetyl-2-amino-3-methylpentanoic acids
Yajima, Tatsuo,Kimura, Makiko,Nakakoji, Mami,Horikawa, Takao,Tokuyama, Yurie,Shiraiwa, Tadashi
, p. 2293 - 2298 (2009)
An X-ray crystal structural analysis revealed that (2S,3S)-N-acetyl-2- amino-3-methylpentanoic acid (N- acetyl-l-isoleucine; Ac-l-I1e) and (2R,3S)-N-acetyl-2- amino-3-methylpentanoic acid (N-acetyl-d-alloisoleucine; Ac-d-aIle) formed a molecular compound containing one Ac-l-Ile molecule and one Ac-d-aIle molecule as an unsymmetrical unit. This molecular compound is packed with strong hydrogen bonds forming homogeneous chains consisting of Ac-l-Ile molecules or Ac-d- aIle molecules and weak hydrogen bonds connecting these homogeneous chains in a fashion similar to that observed for Ac-l-Ile and Ac-d-aIle. Recrystallization of an approximately 1:1 mixture of Ac-l-Ile and Ac-d-aIle from water gave an equimolar molecular compound due to its lower solubility than that of Ac-d-aIle or especially Ac-l-Ile. The results suggest that the equimolar mixture of Ac-l-Ile and Ac-d-aIle could be obtained from an Ac-l-Ile-excess mixture by recystallization from water.
Bio- And Medicinally Compatible α-Amino-Acid Modification via Merging Photoredox and N-Heterocyclic Carbene Catalysis
Chen, Lei,Du, Ding,Feng, Jie,Gao, Jian,Lu, Tao,Ma, Rui,Shi, Zhihao,Zhang, Kuili
supporting information, (2020/09/02)
An N-heterocyclic carbene and photoredox cocatalyzed α-amino-acid decarboxylative carbonylation reaction is presented. This method displays good scope generality, providing a direct pathway to access various downstream α-amino ketones under bio- and medicinally compatible conditions. Moreover, this strategy is appealing to chemical biology because it has great potential for the chemical modification of peptides or the late-stage synthesis of keto-peptides.
GRANZYME B DIRECTED IMAGING AND THERAPY
-
Page/Page column 108; 109; 146, (2019/09/04)
Provided herein are heterocyclic compounds useful for imaging Granzyme B. Methods of imaging Granzyme B, combination therapies, and kits comprising the Granzyme B imaging agents are also provided.